Literature DB >> 3846593

Staphylocoagulase-binding region in human prothrombin.

S Kawabata, T Morita, S Iwanaga, H Igarashi.   

Abstract

A staphylocoagulase-binding region in human prothrombin was studied by utilizing several fragments prepared from prothrombin by limited proteolysis. Bovine prothrombin, prethrombin 1, prethrombin 2, and human diisopropylphosphorylated alpha-thrombin strongly inhibited formation of the complex ("staphylothrombin") between human prothrombin and staphylocoagulase, but bovine prothrombin fragment 1 and fragment 2 had no effect on the complex formation, indicating that the binding region of human prothrombin for staphylocoagulase is located in the prethrombin 2 molecule. To identify further the staphylocoagulase-binding region, human alpha-thrombin was cleaved into the NH2-terminal large fragment (Mr = 26,000) and the COOH-terminal fragment (Mr = 16,000) by porcine pancreatic elastase. Of these fragments, the COOH-terminal fragment, which includes Asn-200 to the COOH-terminal end of the alpha-thrombin molecule, partially inhibited the complex formation between staphylocoagulase and human prothrombin. In contrast, the NH2-terminal large fragment did not show any inhibitory effect on the staphylothrombin formation. These results suggest that the staphylocoagulase interacts with human prothrombin through the COOH-terminal region of alpha-thrombin B chain. Other plasma proteins, factor X, factor IX, protein C, protein S, protein Z, all of which are structurally similar to prothrombin, did not inhibit the staphylothrombin formation at all, indicating that a specific interaction site with staphylocoagulase is contained only in the prothrombin molecule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3846593     DOI: 10.1093/oxfordjournals.jbchem.a135057

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  Ionic interactions in the formation of the thrombin-hirudin complex.

Authors:  A Betz; J Hofsteenge; S R Stone
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

2.  Evidence for common structural changes in thrombin induced by active-site or exosite binding.

Authors:  M A Parry; S R Stone; J Hofsteenge; M P Jackman
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

Review 3.  Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections.

Authors:  Molly McAdow; Dominique M Missiakas; Olaf Schneewind
Journal:  J Innate Immun       Date:  2012-01-03       Impact factor: 7.349

4.  Effect of heparin on the glia-derived-nexin-thrombin interaction.

Authors:  A Wallace; G Rovelli; J Hofsteenge; S R Stone
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

5.  The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.

Authors:  W Bode; D Turk; A Karshikov
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

6.  Catalytically competent human and bovine zeta-thrombin and chimeras generated from unfolded polypeptide chains.

Authors:  S D Lewis; D V Brezniak; J W Fenton; J A Shafer
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

7.  Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.

Authors:  H C Whinna; F C Church
Journal:  J Protein Chem       Date:  1993-12

8.  The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.

Authors:  W Bode; I Mayr; U Baumann; R Huber; S R Stone; J Hofsteenge
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

9.  The Complex Fibrinogen Interactions of the Staphylococcus aureus Coagulases.

Authors:  Sheila Thomas; Wen Liu; Srishtee Arora; Vannakambodi Ganesh; Ya-Ping Ko; Magnus Höök
Journal:  Front Cell Infect Microbiol       Date:  2019-04-16       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.